Focuses on the pharmacological prevention of Parkinson disease (PD) in Drosophila. Defining pathogenic feature of PD; Examination of whether pharmacological enhancement of chaperone activity might be an effective therapeutic approach by which to delay or prevent the progressive degeneration of dopaminergic neurons in PD.